Clinical Trial Update: MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040) [Phase 3]

View source ↗

Summary

A Phase 3 monotherapy trial of MK0431 in patients with Type 2 Diabetes Mellitus has completed, and results were posted in 2010. The study was sponsored by Merck…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK0431

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2010-04-02